Results 151 to 160 of about 96,164 (192)

Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitis. [PDF]

JHEP Rep
Chien SC, Chen CY, Tsai HW, Lin YJ, Shiesh SC, Cheng PN, Chiu HC, Chiu YC, Lin YH, Wu MS, Zheng MJ, Young KC, Tsai YS.   +12 more
europepmc   +1 more source

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026. [PDF]

Diabetes Care
American Diabetes Association Professional Practice Committee for Diabetes* .
europepmc   +1 more source

Diabetes and the liver. [PDF]

Clin Med (Lond)
Dadey E, Lim TY, Makaronidis J.
europepmc   +1 more source

Disparities in liver transplantation for metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma. [PDF]

World J Transplant
Victor DW, Kodali S, Noureddin M, Brombosz EW, Lopez A, Basra T, Graviss EA, Nguyen DT, Saharia A, Connor AA, Abdelrahim M, Cheah YL, Simon CJ, Hobeika MJ, Mobley CM, Ghobrial RM.   +15 more
europepmc   +1 more source

Burden and trends of nonalcoholic steatohepatitis-related liver cancer in China: A population-based observational study using GBD 2021 data. [PDF]

Medicine (Baltimore)
Xiang MX, Yan P, Lan B, Deng JB, Tan J.
europepmc   +1 more source

Correction: Exploring the mechanisms of tetrahydrocurcumin in ameliorating nonalcoholic steatohepatitis based on network pharmacology and gut microbiota analysis <i>in vivo</i> and <i>in vitro</i>. [PDF]

Front Microbiol
Chen K, Wang J, Luo S, Quan Y, Wei P, Fu J, Ma J, Yang Y, Liu Y, Gao Z.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Nonalcoholic steatohepatitis

Current Treatment Options in Gastroenterology, 2004
Nonalcoholic steatohepatitis (NASH) is an important medical condition and there is great public health concern related to its increasing incidence and potential implications for the development of end-stage liver disease. NASH represents a progression beyond simple lipid deposition in the liver parenchyma, requiring histologic evidence for hepatocyte ...
Brian P, Mulhall, Zobair M, Younossi
  +8 more sources

Nonalcoholic Steatohepatitis

JAMA, 2020
Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD) and is associated with disease progression, development of cirrhosis, and need for liver transplant. Despite its importance, NASH is underrecognized in clinical practice.NASH affects an estimated 3% to 6% of the US population and the prevalence ...
Adam C, Sheka, Oyedele, Adeyi, Julie, Thompson, Bilal, Hameed, Peter A, Crawford, Sayeed, Ikramuddin   +5 more
openaire   +4 more sources

Nonalcoholic Steatohepatitis

Annals of Internal Medicine, 1997
To determine the clinical relevance of nonalcoholic steatohepatitis (NASH) and to review the available literature on the epidemiology, clinical features, histology, pathogenesis, clinical course, and management of this condition.Pertinent articles in English identified through a MEDLINE search (1966 to the present) and the bibliographies of relevant ...
S G, Sheth, F D, Gordon, S, Chopra
openaire   +4 more sources